SCHEMBL18060636

SCHEMBL18060636

C/C=C/C(=O)Nc1cccc(Sc2c(OC)nc(N3CCN(C)CC3)nc2OC)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK3 P52333 5/20 0.45
▸ JAK1 P23458 2/20 0.45
▸ MAPT P10636 3/20 0.41
▸ TP53 P04637 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ ERBB2 P04626 1/20 0.41
▸ EGFR P00533 5/20 0.40
▸ UCHL3 P15374 1/20 0.39
▸ CTSC P53634 5/20 0.38
▸ JAK2 O60674 2/20 0.38
▸ BLK P51451 2/20 0.38
▸ BMX P51813 2/20 0.38
▸ PLK4 O00444 1/20 0.38
▸ GAK O14976 1/20 0.38
▸ NUAK1 O60285 1/20 0.38
▸ FLT3 P36888 1/20 0.38
▸ PTK2 Q05397 1/20 0.38
▸ BTK Q06187 1/20 0.38
▸ ITK Q08881 1/20 0.38
▸ ERBB4 Q15303 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18060638 1.00 JAK3 (0.45) JAK3JAK1MAPTTP53SMN1; SMN2
SCHEMBL12806084 0.90 UCHL3 (0.51) JAK3JAK1ERBB2EGFRUCHL3
SCHEMBL12805460 0.88 JAK3 (0.47) JAK3JAK1MAPTTP53SMN1; SMN2
SCHEMBL12805463 0.88 JAK3 (0.47) JAK3JAK1MAPTTP53SMN1; SMN2
SCHEMBL1275994 0.85 NPC1 (0.48) JAK3MAPTSMN1; SMN2EGFRNUAK1
SCHEMBL1276167 0.85 SMN1; SMN2 (0.44) MAPTSMN1; SMN2EGFRNUAK1NUAK2
SCHEMBL18061042 0.84 MAPT (0.41) JAK3MAPTSMN1; SMN2ERBB2EGFR
SCHEMBL1275384 0.84 RAB9A (0.47) TP53SMN1; SMN2FLT3BTKALDH1A1
SCHEMBL12806256 0.84 MEN1 (0.49) MAPTTP53PLK4BTKALDH1A1
SCHEMBL1275156 0.83 TSHR (0.48) MAPTTP53ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3205647-B1 2-(PYRIMIDIN-5-YL)-THIOPYRIMIDINE DERIVATIVES AS HSP70 AND HSC70 MODULATORS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS MEMORIAL SLOAN KETTERING CANCER CENTER (US) 2020-05-13 — — EP disclosed
EP-3205647-A2 2-(PYRIMIDIN-5-YL)-THIOPYRIMIDINE DERIVATIVES AS HSP70 AND HSC70 MODULATORS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Memorial Sloan-Kettering Cancer Center (US) 2017-08-16 — — EP disclosed
EP-2467142-B1 2-(Pyrimidin-5-yl)-thiopyrimidine derivatives as Hsp70 and Hsc70 modulators for the treatment of proliferative disorders SLOAN KETTERING INST CANCER (US) 2016-09-21 — — EP disclosed
Send feedback